# Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®

> **NCT00532012** · PHASE1 · COMPLETED · sponsor: **MediGene** · enrollment: 10 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** RhuDex®

## Key facts

- **NCT ID:** NCT00532012
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2007-10
- **Final completion:** 2007-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2008-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532012, "Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00532012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*